A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Based on a precise diagnostic standard process, through a multicenter study, we will establish a cohort focusing on placenta-mediated fetal growth restriction (FGR). Long-term follow-up will be conducted to seek predictive indicators for short-term and long-term adverse outcomes of maternal vascular malperfusion-related FGR (MVM-FGR).

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Singleton pregnancy 2. diagnosed as FGR according the delphi consensus:

⁃ Early-onset FGR(\<32 weeks) Estimated fetal weight (EFW) or abdominal circumference (AC) \< 3rd; or EFW or AC \< 10th, combined with abnormal doppler, including uterine artery pulsatility index(UtA PI) \>95th percentile, umbilical artery pulsatility index(UA PI) \>95th percentile; or umbilical artery absent end-diastolic flow (UA-AEDF) or umbilical artery reversed end-diastolic flow(UA-REDF).

⁃ Late-onset FGR(≥32 weeks) Estimated fetal weight (EFW) or abdominal circumference (AC) \< 3rd; or \>2 of the following 3 criteria:

∙ EFW or AC \<10th percentile

‣ EFW or AC crossing percentiles\>2 quartiles on growth percentiles

‣ CPR \<5th percentile or UA-Pl\>95th percentile 3.provision of signed written informed consent.

Locations
Other Locations
China
Shanghai First Maternity and Infant Hospital
RECRUITING
Shanghai
Contact Information
Primary
Jianping Chen, Master
urchin_chen@163.com
+86 13916159565
Time Frame
Start Date: 2023-08-10
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: Shanghai First Maternity and Infant Hospital

This content was sourced from clinicaltrials.gov